Erypharm
Paris
About Erypharm
EryPharm is a biotech business that produces red blood cells for industrial use from stem cells. They produce cultured red blood cells, creating blood transfusion products. Their product notably is for the treatment of blood disorders and cancer patients, who require multiple transfusions.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $18.0M
- Funding stage: Seed
- Last round: Seed (Jul 2016)
- Website: erypharm.com
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/erypharm-69841 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.